Currently out of the existing stock ratings of Stephen Unger, 70 are a BUY (90.91%), 6 are a HOLD (7.79%), 1 are a SELL (1.3%).

Stephen Unger

Work Performance Price Targets & Ratings Chart

Analyst Stephen Unger, carries an average stock price target met ratio of 88.86% that have a potential upside of 28.56% achieved within 128 days. Previously, Stephen Unger worked at NEEDHAM.

Stephen Unger’s has documented 132 price targets and ratings displayed on 14 stocks. The coverage was on Healthcare, Technology, Industrials sectors.

Most recent stock forecast was given on NEO, NeoGenomics at 29-Mar-2022.

Wall Street Analyst Stephen Unger

Analyst best performing recommendations are on OCX (ONCOCYTE CORP).
The best stock recommendation documented was for OCX (ONCOCYTE CORP) at 11/13/2020. The price target of $4 was fulfilled within 68 days with a profit of $2.26 (129.89%) receiving and performance score of 19.1.

Average potential price target upside

of $51.17 (16.42%) on TMO (THERMO FISHER SCIENTIFIC).
of $31.48 (26.62%) on PKI (PERKINELMER).
of $18.81 (14.08%) on DHR (DANAHER).

BRKR Bruker BRKS Brooks Automation DHR Danaher NEO NeoGenomics TMO Thermo Fisher Scientific A Agilent Technologies CYRX Cryoport AZTA Azenta VCYT Veracyte GHDX Genomic Health MYGN Myriad Genetics OCX OncoCyte Corp PKI PerkinElmer PSNL Personalis

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Luke Sergott (BARCLAYS)